ATAI
Atai Beckley N.VNASDAQHealthcare$3.79+2.43%ClosedMarket Cap: $714.9M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
5.45
P/S
177.60
EV/EBITDA
-5.69
DCF Value
$0.18
FCF Yield
-15.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
75.3%
Operating Margin
-2789.5%
Net Margin
-16142.0%
ROE
-389.7%
ROA
-212.5%
ROIC
-39.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $1.1M | 1021.8% | $-43.0M | $-544.8M | $-1.73 | — |
| FY 2025 | $4.1M | 75.3% | $-114.1M | $-660.0M | $-2.91 | — |
| Q3 2025 | $749.0K | 100.0% | $-28.4M | $-61.1M | $-0.28 | — |
| Q2 2025 | $719.0K | 100.0% | $-25.3M | $-27.7M | $-0.14 | — |
| Q1 2025 | $1.6M | -597.0% | $-20.4M | $-26.4M | $-0.15 | — |
| Q4 2024 | $-5.0K | 100.0% | $-30.3M | $-39.0M | $-0.24 | — |
| FY 2024 | $308.0K | 100.0% | $-102.7M | $-149.3M | $-0.93 | — |
| Q3 2024 | $40.0K | 100.0% | $-22.6M | $-26.3M | $-0.16 | — |
| Q2 2024 | $273.0K | 100.0% | $-25.7M | $-57.3M | $-0.36 | — |
| Q1 2024 | $0.00 | -Infinity% | $-24.1M | $-26.7M | $-0.17 | — |
| Q4 2023 | $18.0K | -461.1% | $-33.6M | $-18.3M | $-0.12 | — |
| FY 2023 | $314.0K | 100.0% | $-125.5M | $-40.2M | $-0.25 | — |